15-22786677-A-T
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_StrongBP7
The NM_144599.5(NIPA1):c.21A>T(p.Ala7Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000108 in 926,094 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. A7A) has been classified as Likely benign.
Frequency
Consequence
NM_144599.5 synonymous
Scores
Clinical Significance
Conservation
Publications
- hereditary spastic paraplegia 6Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_144599.5. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NIPA1 | TSL:1 MANE Select | c.21A>T | p.Ala7Ala | synonymous | Exon 1 of 5 | ENSP00000337452.4 | Q7RTP0-1 | ||
| NIPA1 | TSL:1 | c.-48+12364A>T | intron | N/A | ENSP00000393962.2 | Q7RTP0-2 | |||
| NIPA1 | TSL:1 | c.-48+429A>T | intron | N/A | ENSP00000453722.1 | Q7RTP0-2 |
Frequencies
GnomAD3 genomes Cov.: 27
GnomAD4 exome AF: 0.00000108 AC: 1AN: 926094Hom.: 0 Cov.: 20 AF XY: 0.00 AC XY: 0AN XY: 442826 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome Cov.: 27
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.